{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:44:25Z","timestamp":1776278665827,"version":"3.50.1"},"reference-count":106,"publisher":"Oxford University Press (OUP)","issue":"D1","license":[{"start":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T00:00:00Z","timestamp":1665878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR21H300001"],"award-info":[{"award-number":["LR21H300001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1909208"],"award-info":[{"award-number":["U1909208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872798"],"award-info":[{"award-number":["81872798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High-Level Talents Special Support Plan of China"},{"name":"Fundamental Research Fund of Central University","award":["2018QNA7023"],"award-info":[{"award-number":["2018QNA7023"]}]},{"name":"Key R&D Program of Zhejiang Province","award":["2020C03010"],"award-info":[{"award-number":["2020C03010"]}]},{"name":"Chinese \u2018Double Top-Class\u2019 Universities","award":["181201*194232101"],"award-info":[{"award-number":["181201*194232101"]}]},{"name":"Westlake Laboratory"},{"name":"Alibaba-Zhejiang University"},{"name":"Alibaba Cloud"},{"name":"Information Tech Center of Zhejiang University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Widespread drug resistance has become the key issue in global healthcare. Extensive efforts have been made to reveal not only diverse diseases experiencing drug resistance, but also the six distinct types of molecular mechanisms underlying this resistance. A database that describes a comprehensive list of diseases with drug resistance (not just cancers\/infections) and all types of resistance mechanisms is now urgently needed. However, no such database has been available to date. In this study, a comprehensive database describing drug resistance information named \u2018DRESIS\u2019 was therefore developed. It was introduced to (i) systematically provide, for the first time, all existing types of molecular mechanisms underlying drug resistance, (ii) extensively cover the widest range of diseases among all existing databases and (iii) explicitly describe the clinically\/experimentally verified resistance data for the largest number of drugs. Since drug resistance has become an ever-increasing clinical issue, DRESIS is expected to have great implications for future new drug discovery and clinical treatment optimization. It is now publicly accessible without any login requirement at: https:\/\/idrblab.org\/dresis\/<\/jats:p>","DOI":"10.1093\/nar\/gkac812","type":"journal-article","created":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T09:46:52Z","timestamp":1665913612000},"page":"D1263-D1275","source":"Crossref","is-referenced-by-count":65,"title":["DRESIS: the first comprehensive landscape of drug resistance information"],"prefix":"10.1093","volume":"51","author":[{"given":"Xiuna","family":"Sun","sequence":"first","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"},{"name":"Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Alibaba\u2013Zhejiang University Joint Research Center of Future Digital Healthcare , Hangzhou 330110, China"}]},{"given":"Yintao","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"}]},{"given":"Hanyang","family":"Li","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"}]},{"given":"Shuiyang","family":"Shi","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"},{"name":"Zhejiang University\u2013University of Edinburgh Institute, Zhejiang University , Haining 314499, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4728-7702","authenticated-orcid":false,"given":"Hanyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"}]},{"given":"Fengcheng","family":"Li","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"}]},{"given":"Jiayi","family":"Yin","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7619-2975","authenticated-orcid":false,"given":"Minjie","family":"Mou","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"}]},{"given":"Yunzhu","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"}]},{"given":"Yunqing","family":"Qiu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-0053","authenticated-orcid":false,"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058, China"},{"name":"Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Alibaba\u2013Zhejiang University Joint Research Center of Future Digital Healthcare , Hangzhou 330110, China"}]}],"member":"286","published-online":{"date-parts":[[2022,10,16]]},"reference":[{"key":"2023010804203147800_B1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/prot.25473","article-title":"Large scale ab initio modeling of structurally uncharacterized antimicrobial peptides reveals known and novel folds","volume":"86","author":"Kozic","year":"2018","journal-title":"Proteins"},{"key":"2023010804203147800_B2","first-page":"874","article-title":"HIV drug resistance","volume":"378","author":"Bertagnolio","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"2023010804203147800_B3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/d41573-020-00050-y","article-title":"Stemming the tide of drug resistance in cancer","volume":"19","author":"Mullard","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023010804203147800_B4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","article-title":"Kinase drug discovery 20 years after imatinib: progress and future directions","volume":"20","author":"Cohen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023010804203147800_B5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jmgm.2019.03.018","article-title":"Molecular dynamics investigation on the asciminib resistance mechanism of I502L and V468F mutations in BCR-ABL","volume":"89","author":"Zhan","year":"2019","journal-title":"J. Mol. Graph. Model"},{"key":"2023010804203147800_B6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acschemneuro.1c00694","article-title":"Molecular mechanism for the allosteric inhibition of the human serotonin transporter by antidepressant escitalopram","volume":"13","author":"Xue","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"2023010804203147800_B7","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1039\/C7CP07869B","article-title":"Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder","volume":"20","author":"Xue","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"2023010804203147800_B8","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0140-6736(20)32598-8","article-title":"Enhancing anti-tumour efficacy with immunotherapy combinations","volume":"397","author":"Meric-Bernstam","year":"2021","journal-title":"Lancet"},{"key":"2023010804203147800_B9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/CMR.00115-20","article-title":"New beta-lactam\u2013beta-lactamase inhibitor combinations","volume":"34","author":"Yahav","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"2023010804203147800_B10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00018-018-2967-9","article-title":"Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma","volume":"76","author":"Buondonno","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"2023010804203147800_B11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood-2018-07-862953","article-title":"Bruton tyrosine kinase degradation as a therapeutic strategy for cancer","volume":"133","author":"Dobrovolsky","year":"2019","journal-title":"Blood"},{"key":"2023010804203147800_B12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymeth.2019.02.009","article-title":"Deep-Resp-Forest: a deep forest model to predict anti-cancer drug response","volume":"166","author":"Su","year":"2019","journal-title":"Methods"},{"key":"2023010804203147800_B13","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1158\/0008-5472.CAN-18-2839","article-title":"Anti-CD24 antibody\u2013nitric oxide conjugate selectively and potently suppresses hepatic carcinoma","volume":"79","author":"Sun","year":"2019","journal-title":"Cancer Res."},{"key":"2023010804203147800_B14","doi-asserted-by":"crossref","first-page":"10927","DOI":"10.1021\/acs.jmedchem.9b00446","article-title":"Drug discovery targeting anaplastic lymphoma kinase (ALK)","volume":"62","author":"Kong","year":"2019","journal-title":"J. Med. Chem."},{"key":"2023010804203147800_B15","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1039\/C9CP06657H","article-title":"Revealing the binding and drug resistance mechanism of amprenavir, indinavir, ritonavir, and nelfinavir complexed with HIV-1 protease due to double mutations G48T\/L89M by molecular dynamics simulations and free energy analyses","volume":"22","author":"Wang","year":"2020","journal-title":"Phys. Chem. Chem. Phys."},{"key":"2023010804203147800_B16","doi-asserted-by":"crossref","first-page":"13899","DOI":"10.1021\/acs.jmedchem.0c01435","article-title":"General strategy for integrated bioorthogonal prodrugs: Pt(II)-triggered depropargylation enables controllable drug activation in vivo","volume":"63","author":"Sun","year":"2020","journal-title":"J. Med. Chem."},{"key":"2023010804203147800_B17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"2023010804203147800_B18","doi-asserted-by":"crossref","first-page":"100833","DOI":"10.1016\/j.drup.2022.100833","article-title":"The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells","volume":"62","author":"Xavier","year":"2022","journal-title":"Drug Resist. Updat."},{"key":"2023010804203147800_B19","doi-asserted-by":"crossref","first-page":"100643","DOI":"10.1016\/j.drup.2019.100643","article-title":"What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg","volume":"46","author":"Alexa-Stratulat","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"2023010804203147800_B20","doi-asserted-by":"crossref","first-page":"D1417","DOI":"10.1093\/nar\/gkab1013","article-title":"VARIDT 2.0: structural variability of drug transporter","volume":"50","author":"Fu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B21","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acschemneuro.7b00490","article-title":"What contributes to serotonin\u2013norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation","volume":"9","author":"Xue","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"2023010804203147800_B22","doi-asserted-by":"crossref","first-page":"bbac253","DOI":"10.1093\/bib\/bbac253","article-title":"ConSIG: consistent discovery of molecular signature from OMIC data","volume":"23","author":"Li","year":"2022","journal-title":"Brief. Bioinform"},{"key":"2023010804203147800_B23","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1021\/acs.chemrev.0c00383","article-title":"Challenges and opportunities in cancer drug resistance","volume":"121","author":"Ward","year":"2021","journal-title":"Chem. Rev."},{"key":"2023010804203147800_B24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41596-021-00636-9","article-title":"Optimization of metabolomic data processing using NOREVA","volume":"17","author":"Fu","year":"2022","journal-title":"Nat. Protoc."},{"key":"2023010804203147800_B25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41591-019-0420-8","article-title":"Rational design of anti-GITR-based combination immunotherapy","volume":"25","author":"Zappasodi","year":"2019","journal-title":"Nat. Med."},{"key":"2023010804203147800_B26","doi-asserted-by":"crossref","first-page":"bbab138","DOI":"10.1093\/bib\/bbab138","article-title":"Pharmacometabonomics: data processing and statistical analysis","volume":"22","author":"Fu","year":"2021","journal-title":"Brief. Bioinform."},{"key":"2023010804203147800_B27","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.3390\/cells10112886","article-title":"Different ability of multidrug-resistant and -sensitive counterpart cells to release and capture extracellular vesicles","volume":"10","author":"Sousa","year":"2021","journal-title":"Cells"},{"key":"2023010804203147800_B28","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/acschemneuro.8b00059","article-title":"Exploring the binding mechanism of metabotropic glutamate receptor 5 negative allosteric modulators in clinical trials by molecular dynamics simulations","volume":"9","author":"Fu","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"2023010804203147800_B29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrg3922","article-title":"Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms","volume":"16","author":"Hughes","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"2023010804203147800_B30","doi-asserted-by":"crossref","first-page":"bbab582","DOI":"10.1093\/bib\/bbab582","article-title":"Identification of drug\u2013target interactions via multiple kernel-based triple collaborative matrix factorization","volume":"23","author":"Ding","year":"2022","journal-title":"Brief. Bioinform."},{"key":"2023010804203147800_B31","doi-asserted-by":"crossref","first-page":"D651","DOI":"10.1093\/nar\/gkaa899","article-title":"BastionHub: a universal platform for integrating and analyzing substrates secreted by Gram-negative bacteria","volume":"49","author":"Wang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/bib\/bby130","article-title":"Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs","volume":"21","author":"Li","year":"2020","journal-title":"Brief. Bioinform."},{"key":"2023010804203147800_B33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature17963","article-title":"Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor","volume":"534","author":"Rodrik-Outmezguine","year":"2016","journal-title":"Nature"},{"key":"2023010804203147800_B34","doi-asserted-by":"crossref","first-page":"bbab083","DOI":"10.1093\/bib\/bbab083","article-title":"Comprehensive assessment of machine learning-based methods for predicting antimicrobial peptides","volume":"22","author":"Xu","year":"2021","journal-title":"Brief. Bioinform."},{"key":"2023010804203147800_B35","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"2023010804203147800_B36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(18)30904-5","article-title":"Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study","volume":"20","author":"Meric-Bernstam","year":"2019","journal-title":"Lancet Oncol."},{"key":"2023010804203147800_B37","doi-asserted-by":"crossref","first-page":"105975","DOI":"10.1016\/j.phrs.2021.105975","article-title":"Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein","volume":"175","author":"Abd-Ellatef","year":"2022","journal-title":"Pharmacol. Res."},{"key":"2023010804203147800_B38","doi-asserted-by":"crossref","first-page":"bbac040","DOI":"10.1093\/bib\/bbac040","article-title":"POSREG: proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability","volume":"23","author":"Li","year":"2022","journal-title":"Brief. Bioinform"},{"key":"2023010804203147800_B39","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"2023010804203147800_B40","doi-asserted-by":"crossref","first-page":"e00047","DOI":"10.1128\/CMR.00047-19","article-title":"Epidemiology of beta-lactamase-producing pathogens","volume":"33","author":"Bush","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"2023010804203147800_B41","doi-asserted-by":"crossref","first-page":"105825","DOI":"10.1016\/j.compbiomed.2022.105825","article-title":"REGLIV: molecular regulation data of diverse living systems facilitating current multiomics research","volume":"148","author":"Zhang","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"2023010804203147800_B42","doi-asserted-by":"crossref","first-page":"348ra397","DOI":"10.1126\/scitranslmed.aaf3124","article-title":"Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin","volume":"8","author":"Liu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"2023010804203147800_B43","doi-asserted-by":"crossref","first-page":"bbab397","DOI":"10.1093\/bib\/bbab397","article-title":"RNA\u2013RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection","volume":"23","author":"Zhang","year":"2021","journal-title":"Brief. Bioinform."},{"key":"2023010804203147800_B44","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/acschemneuro.8b00729","article-title":"How does chirality determine the selective inhibition of histone deacetylase 6? A lesson from trichostatin A enantiomers based on molecular dynamics","volume":"10","author":"Zhang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"2023010804203147800_B45","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.drup.2019.100663","article-title":"Targeting the ubiquitin\u2013proteasome pathway to overcome anti-cancer drug resistance","volume":"48","author":"Narayanan","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"2023010804203147800_B46","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1021\/acs.jmedchem.1c02194","article-title":"Protein S-nitrosation: biochemistry, identification, molecular mechanisms, and therapeutic applications","volume":"65","author":"Ye","year":"2022","journal-title":"J. Med. Chem."},{"key":"2023010804203147800_B47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-019-0965-7","article-title":"Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance","volume":"18","author":"Maacha","year":"2019","journal-title":"Mol. Cancer"},{"key":"2023010804203147800_B48","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/cells9051141","article-title":"The role of extracellular vesicles in the hallmarks of cancer and drug resistance","volume":"9","author":"Xavier","year":"2020","journal-title":"Cells"},{"key":"2023010804203147800_B49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41579-021-00649-x","article-title":"Antibiotic resistance in the environment","volume":"20","author":"Larsson","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"2023010804203147800_B50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semcancer.2021.03.014","article-title":"miRNAs mediated drug resistance in hematological malignancies","volume":"83","author":"Peixoto\u00a0da\u00a0Silva","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"2023010804203147800_B51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-pharmtox-010715-103111","article-title":"Toward a better understanding of the complexity of cancer drug resistance","volume":"56","author":"Gottesman","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2023010804203147800_B52","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1021\/acs.chemrev.1c00118","article-title":"Introduction: drug resistance","volume":"121","author":"Kurt\u00a0Yilmaz","year":"2021","journal-title":"Chem. Rev."},{"key":"2023010804203147800_B53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol. Spectr"},{"key":"2023010804203147800_B54","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ijc.32419","article-title":"Wnt\/IL-1beta\/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5","volume":"146","author":"Milosevic","year":"2020","journal-title":"Int. J. Cancer"},{"key":"2023010804203147800_B55","doi-asserted-by":"crossref","first-page":"100662","DOI":"10.1016\/j.drup.2019.100662","article-title":"Computational approaches in cancer multidrug resistance research: identification of potential biomarkers, drug targets and drug\u2013target interactions","volume":"48","author":"Tolios","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"2023010804203147800_B56","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1038\/s41467-019-12364-6","article-title":"Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance","volume":"10","author":"Spohn","year":"2019","journal-title":"Nat. Commun."},{"key":"2023010804203147800_B57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drup.2016.07.001","article-title":"Old drugs, novel ways out: drug resistance toward cytotoxic chemotherapeutics","volume":"28","author":"Wijdeven","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"2023010804203147800_B58","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/srep01445","article-title":"CancerDR: cancer drug resistance database","volume":"3","author":"Kumar","year":"2013","journal-title":"Sci. Rep."},{"key":"2023010804203147800_B59","doi-asserted-by":"crossref","first-page":"D552","DOI":"10.1093\/nar\/gkaa945","article-title":"KinaseMD: kinase mutations and drug response database","volume":"49","author":"Hu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B60","doi-asserted-by":"crossref","first-page":"D371","DOI":"10.1093\/nar\/gkl855","article-title":"The HIV positive selection mutation database","volume":"35","author":"Pan","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B61","doi-asserted-by":"crossref","first-page":"D566","DOI":"10.1093\/nar\/gks1022","article-title":"HBVdb: a knowledge database for hepatitis B virus","volume":"41","author":"Hayer","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B62","first-page":"D517","article-title":"CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database","volume":"48","author":"Alcock","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B63","doi-asserted-by":"crossref","first-page":"D561","DOI":"10.1093\/nar\/gkz1010","article-title":"MEGARes 2.0: a database for classification of antimicrobial drug, biocide and metal resistance determinants in metagenomic sequence data","volume":"48","author":"Doster","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B64","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1093\/bioinformatics\/bty321","article-title":"MARDy: mycology antifungal resistance database","volume":"34","author":"Nash","year":"2018","journal-title":"Bioinformatics"},{"key":"2023010804203147800_B65","first-page":"D118","article-title":"LncTarD: a manually-curated database of experimentally-supported functional lncRNA\u2013target regulations in human diseases","volume":"48","author":"Zhao","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B66","doi-asserted-by":"crossref","first-page":"D86","DOI":"10.1093\/nar\/gkaa1076","article-title":"EVLncRNAs 2.0: an updated database of manually curated functional long non-coding RNAs validated by low-throughput experiments","volume":"49","author":"Zhou","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B67","doi-asserted-by":"crossref","first-page":"baz074","DOI":"10.1093\/database\/baz074","article-title":"MycoResistance: a curated resource of drug resistance molecules in mycobacteria","volume":"2019","author":"Dai","year":"2019","journal-title":"Database"},{"key":"2023010804203147800_B68","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/1471-2164-15-308","article-title":"Genome-wide Mycobacterium tuberculosis variation (GMTV) database: a new tool for integrating sequence variations and epidemiology","volume":"15","author":"Chernyaeva","year":"2014","journal-title":"BMC Genomics"},{"key":"2023010804203147800_B69","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B70","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B71","doi-asserted-by":"crossref","first-page":"D1184","DOI":"10.1093\/nar\/gkab860","article-title":"CTR-DB, an omnibus for patient-derived gene expression signatures correlated with cancer drug response","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B72","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00125-019-4909-y","article-title":"Type 2 diabetes: a multifaceted disease","volume":"62","author":"Pearson","year":"2019","journal-title":"Diabetologia"},{"key":"2023010804203147800_B73","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/s41380-021-01331-7","article-title":"A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistance","volume":"27","author":"Yang","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"2023010804203147800_B74","doi-asserted-by":"crossref","first-page":"118589","DOI":"10.1016\/j.lfs.2020.118589","article-title":"Cellular plasticity and drug resistance in sarcoma","volume":"263","author":"Lin","year":"2020","journal-title":"Life Sci."},{"key":"2023010804203147800_B75","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41467-021-21177-5","article-title":"Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma","volume":"12","author":"Samur","year":"2021","journal-title":"Nat. Commun."},{"key":"2023010804203147800_B76","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1021\/acs.jpclett.0c03560","article-title":"In silico analysis revealed a unique binding but ineffective mode of amantadine to influenza virus B M2 channel","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Phys. Chem. Lett."},{"key":"2023010804203147800_B77","doi-asserted-by":"crossref","first-page":"k1452","DOI":"10.1136\/bmj.k1452","article-title":"How to avoid common problems when using clinicaltrials.gov in research: 10 issues to consider","volume":"361","author":"Tse","year":"2018","journal-title":"BMJ"},{"key":"2023010804203147800_B78","doi-asserted-by":"crossref","first-page":"D1398","DOI":"10.1093\/nar\/gkab953","article-title":"Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents","volume":"50","author":"Zhou","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B79","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the drugbank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B80","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","article-title":"A history of cancer chemotherapy","volume":"68","author":"DeVita","year":"2008","journal-title":"Cancer Res."},{"key":"2023010804203147800_B81","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0140-6736(19)31205-X","article-title":"ICD-11","volume":"393","author":"The","year":"2019","journal-title":"Lancet"},{"key":"2023010804203147800_B82","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B83","first-page":"D1031","article-title":"Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics","volume":"48","author":"Wang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B84","doi-asserted-by":"crossref","first-page":"D1042","DOI":"10.1093\/nar\/gkz779","article-title":"VARIDT 1.0: variability of drug transporter database","volume":"48","author":"Yin","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B85","doi-asserted-by":"crossref","first-page":"D1233","DOI":"10.1093\/nar\/gkaa755","article-title":"INTEDE: interactome of drug-metabolizing enzymes","volume":"49","author":"Yin","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B86","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"2023010804203147800_B87","doi-asserted-by":"crossref","first-page":"100670","DOI":"10.1016\/j.drup.2019.100670","article-title":"Phospholipids and cholesterol: inducers of cancer multidrug resistance and therapeutic targets","volume":"49","author":"Kopecka","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"2023010804203147800_B88","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.omtn.2019.04.010","article-title":"Prediction of potential disease-associated microRNAs by using neural networks","volume":"16","author":"Zeng","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2023010804203147800_B89","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1021\/acs.jmedchem.7b01096","article-title":"Novel ligustrazine-based analogs of piperlongumine potently suppress proliferation and metastasis of colorectal cancer cells in vitro and in vivo","volume":"61","author":"Zou","year":"2018","journal-title":"J. Med. Chem."},{"key":"2023010804203147800_B90","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/jpp\/rgaa031","article-title":"The role of microRNAs on doxorubicin drug resistance in breast cancer","volume":"73","author":"Jamialahmadi","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"key":"2023010804203147800_B91","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1021\/acs.jafc.0c00107","article-title":"Beta-sitosterol reverses multidrug resistance via BCRP suppression by inhibiting the p53\u2013MDM2 interaction in colorectal cancer","volume":"68","author":"Wang","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"2023010804203147800_B92","doi-asserted-by":"crossref","first-page":"352ra109","DOI":"10.1126\/scitranslmed.aaf9074","article-title":"ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: a rationale for safer glucocorticoid replacement therapy","volume":"8","author":"Nixon","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"2023010804203147800_B93","doi-asserted-by":"crossref","first-page":"104023","DOI":"10.1016\/j.jprot.2020.104023","article-title":"MMEASE: online meta-analysis of metabolomic data by enhanced metabolite annotation, marker selection and enrichment analysis","volume":"232","author":"Yang","year":"2021","journal-title":"J. Proteomics"},{"key":"2023010804203147800_B94","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1124\/dmd.117.078840","article-title":"CYP2J2 expression in adult ventricular myocytes protects against reactive oxygen species toxicity","volume":"46","author":"Evangelista","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"2023010804203147800_B95","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/biomedicines10030619","article-title":"Proteomic studies of psoriasis","volume":"10","author":"Sobolev","year":"2022","journal-title":"Biomedicines"},{"key":"2023010804203147800_B96","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2016.01.009","article-title":"The role of glucuronidation in drug resistance","volume":"159","author":"Mazerska","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"2023010804203147800_B97","doi-asserted-by":"crossref","first-page":"D560","DOI":"10.1093\/nar\/gkab926","article-title":"SYNBIP: synthetic binding proteins for research, diagnosis and therapy","volume":"50","author":"Wang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B98","doi-asserted-by":"crossref","first-page":"D1123","DOI":"10.1093\/nar\/gkab957","article-title":"webTWAS: a resource for disease candidate susceptibility genes identified by transcriptome-wide association study","volume":"50","author":"Cao","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B99","doi-asserted-by":"crossref","first-page":"105465","DOI":"10.1016\/j.compbiomed.2022.105465","article-title":"PFmulDL: a novel strategy enabling multi-class and multi-label protein function annotation by integrating diverse deep learning methods","volume":"145","author":"Xia","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"2023010804203147800_B100","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/bib\/bbz081","article-title":"Protein functional annotation of simultaneously improved stability, accuracy and false discovery rate achieved by a sequence-based deep learning","volume":"21","author":"Hong","year":"2020","journal-title":"Brief. Bioinform."},{"key":"2023010804203147800_B101","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2014update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"2023010804203147800_B102","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"Affy\u2014analysis of affymetrix genechip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"2023010804203147800_B103","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1101\/gad.2017311","article-title":"Making sense of cancer genomic data","volume":"25","author":"Chin","year":"2011","journal-title":"Genes Dev."},{"key":"2023010804203147800_B104","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","author":"GTEx Consortium","year":"2017","journal-title":"Nature"},{"key":"2023010804203147800_B105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"2023010804203147800_B106","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygeno.2005.04.008","article-title":"Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues","volume":"86","author":"Ge","year":"2005","journal-title":"Genomics"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/51\/D1\/D1263\/48440662\/gkac812.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/51\/D1\/D1263\/48440662\/gkac812.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T04:22:05Z","timestamp":1673151725000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/51\/D1\/D1263\/6761745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,16]]},"references-count":106,"journal-issue":{"issue":"D1","published-online":{"date-parts":[[2022,10,16]]},"published-print":{"date-parts":[[2023,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkac812","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,6]]},"published":{"date-parts":[[2022,10,16]]}}}